Asuragen, Inc. Launches SuraSeq™ Next Generation Sequencing Services
4/4/2013 11:52:14 AM
More...
|
Asuragen, Inc. Study Finds New Genetic Test Better Predicts Mother's Risk of Having a Child With Fragile X Syndrome
3/21/2013 11:20:15 AM
More...
|
Asuragen, Inc. Collects $7.5 Million Financing
3/21/2013 9:20:34 AM
More...
|
Rolland Carlson, Ph.D. Named CEO of Asuragen, Inc.
1/7/2013 8:05:50 AM
More...
|
Asuragen, Inc. to Present at Upcoming Association for Molecular Pathology Annual Meeting on Genomic Medicine
10/24/2012 9:23:13 AM
More...
|
Asuragen, Inc. Grants Armored RNA® Technology License to Becton, Dickinson and Company (BDX)
6/19/2012 10:57:46 AM
More...
|
Asuragen, Inc. Release: Data Presented at the Annual Meeting of the American Association of Endocrine Surgeons Illustrates the Clinical Utility of miRInform® Thyroid Panel Used in Conjunction with Ultrasound-Guided Fine Needle Aspiration
5/1/2012 10:45:49 AM
More...
|
Asuragen, Inc. Awarded $6.8 Million Commercialization Award from the Cancer Prevention and Research Institute of Texas
3/30/2012 10:50:32 AM
More...
|
FDA Clears Asuragen, Inc.'s RNARetain® Pre-analytical RNA Stabilization Device
3/22/2012 6:42:09 AM
More...
|
Asuragen, Inc. Launches miRInform® Pancreas Test for use on Fine Needle Aspirate Specimens of Pancreatic Masses
2/17/2012 7:20:21 AM
More...
|
|